Monoclonal Antibodies

Dupixent (dupilumab) is used to treat certain patients with eczema, asthma, and nasal polyps. There is currently no generic alternative to Dupixent. It may be covered by your Medicare or insurance plan.

TEZEPELUMAB prevents and treats the symptoms of asthma. It works by decreasing inflammation of the airways, making it easier to breathe. It is prescribed when other asthma medications have not worked well enough. Do not use it to treat a sudden asthma attack. It is a monoclonal antibody.

Bamlanivimab is an investigational monoclonal antibody therapy authorized for emergency use by the FDA to treat COVID-19. It is not yet FDA approved, and the safety and effectiveness of this therapy is still being evaluated.

Casirivimab is an investigational monoclonal antibody therapy authorized for emergency use by the FDA to treat COVID-19. It must be administered together with imdevimab. It is not yet FDA approved, and the safety and effectiveness of this therapy is still being evaluated.

Etesevimab is an investigational monoclonal antibody therapy authorized for emergency use by the FDA to treat COVID-19. It is not yet FDA approved, and the safety and effectiveness of this therapy is still being evaluated.

Imdevimab is an investigational monoclonal antibody therapy authorized for emergency use by the FDA to treat COVID-19. It must be administered together with casirivimanb. It is not yet FDA approved, and the safety and effectiveness of this therapy is still being evaluated.

Bkemv is only available as a brand name drug.

LECANEMAB treats Alzheimer disease. It works by decreasing the buildup of amyloid, a protein that may cause Alzheimer disease. This may slow down the worsening of symptoms. It is a monoclonal antibody.

Pemgarda (pemivibart) is approved under an EUA, or emergency use authorization, for the pre-exposure prophylaxis of COVID-19. There are currently no generic alternatives. It may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

NIVOLUMAB; RELATLIMAB treats skin cancer. It works by helping your immune system slow or stop the spread of cancer cells. It is a monoclonal antibody.

ISATUXIMAB treats a type of bone marrow cancer (multiple myeloma). It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.

TAFASITAMAB treats lymphoma. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. It is a monoclonal antibody.

Gohibic (vilobelimab) is approved under an emergency use authorization (EUA) for the treatment of COVID-19. Gohibic is only available as a brand drug. It may be covered by your Medicare or insurance plan.

Vyloy is part of the Monoclonal Antibodies class and treats Adrenal Cancer. Monoclonal antibodies are used to treat many conditions, including cancers, autoimmune diseases, and certain infections. They are similar to the antibodies in the body's immune system. But they are lab-made to have a specific target based on the condition they treat. Targets can include cancer cells, viruses, immune cells, and certain receptors in the body. Vyloy is only available as a brand name drug.

SUTIMLIMAB treats cold agglutinin disease, an autoimmune condition that breaks down red blood cells in the body. It works by stopping the breakdown of red blood cells, which reduces the need for blood transfusions. It is a monoclonal antibody.

RAVULIZUMAB treats certain blood conditions that can cause low levels of red blood cells (anemia) and blood clots, such as atypical hemolytic uremic syndrome (aHUS) and paroxysmal nocturnal hemoglobinuria (PNH). It works by slowing down an overactive immune system, which reduces the breakdown of red blood cells. It also prevents blood cells (platelets) from forming a clot. It may also be used to treat a condition that causes muscles to easily weaken or fatigue (myasthenia gravis). It can be used to treat neuromyelitis optica spectrum disorder (NMOSD), a condition that causes inflammation in the nerves of the eyes and spinal cord. It is a monoclonal antibody.

ELOTUZUMAB treats multiple myeloma, a type of bone marrow cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells. It is a monoclonal antibody.

Trodelvy (sacituzumab govitecan) is used to treat locally advanced or metastatic breast cancer and locally advanced or metastatic urothelial cancer. There are currently no generic alternatives to trodelvy. It may be covered by your Medicare or insurance plan, but some pharmacy coupons or cash prices could help offset the cost.

ROMOSOZUMAB prevents and treats osteoporosis. It works by making your bones stronger and less likely to break (fracture). It is a monoclonal antibody.

NIRSEVIMAB reduces the risk of infections caused by respiratory syncytial virus (RSV). It does not treat RSV. It is still possible to get RSV after receiving this medication, but the symptoms may be less severe or not last as long. It works by helping your immune system slow or stop the spread of the virus in the body. It is a monoclonal antibody.

ENFORTUMAB VEDOTIN treats bladder cancer and kidney cancer. It works by blocking a protein that causes cancer cells to grow and multiply. This helps to slow or stop the spread of cancer cells.

TREMELIMUMAB treats liver cancer and lung cancer. It works by helping your immune system slow or stop the spread of cancer cells. It is a monoclonal antibody.

BASILIXIMAB prevents the body from rejecting an organ transplant. It works by lowering the body's immune system response. This helps the body accept the donor organ. It belongs to a group of medications called immunosuppressants. It is a monoclonal antibody.

EMAPALUMAB treats hemophagocytic lymphohistiocytosis (HLH), a condition that can cause severe inflammation and tissue injury in the body. It works by slowing down an overactive immune system. This decreases inflammation. It is a monoclonal antibody.

BEZLOTOXUMAB prevents infections caused by the bacteria C. diff (Clostridioides difficile). It is used with antibiotics. It works by binding to a toxin made by the bacteria. This decreases symptoms, such as diarrhea. It is a monoclonal antibody.